CIC
BIIB icon

Canal Insurance Company’s Biogen BIIB Stock Holding History

Canal Insurance Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Sell
10,000
-10,000
-50% -$1.91M 0.47% 52
2026
Q1 		$3.67M Buy
+20,000
New +$3.69M 0.79% 38

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Canal Insurance Company's BIIB Position: Q2 2026 in Review

Canal Insurance Company reduced its Biogen (BIIB) stake by 50% in Q2 2026, selling an estimated $1.91M and leaving 10,000 shares worth $2.16M. The position accounts for 0.47% of the portfolio, ranked #52.

Canal Insurance Company first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.67M in Q1 2026. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Canal Insurance Company held 10,000 shares of Biogen worth $2.16M as of Q2 2026.
  • Canal Insurance Company sold 10,000 Biogen shares in Q2 2026, an estimated $1.91M.
  • Biogen made up 0.47% of Canal Insurance Company's portfolio in Q2 2026, its #52 holding.
  • Canal Insurance Company first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • Canal Insurance Company's Biogen position peaked at $3.67M in Q1 2026.
  • 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.